A recent review linking NONO, circadian regulation, and cancer notes that NONO overexpression or dysfunction is a common feature across multiple tumour types, and its central role in the clock–cell-cycle–metabolism axis positions NONO as a promising anticancer target [7]. Here, CLOCK is linked to neoplasm.